UBS Group AG - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$50,784,000
-7.0%
2,185,154
-36.3%
0.02%
-8.3%
Q1 2018$54,609,000
-14.9%
3,430,231
+11.1%
0.02%
-11.1%
Q4 2017$64,168,000
+132.4%
3,087,960
+60.3%
0.03%
+107.7%
Q3 2017$27,607,000
-32.6%
1,926,532
-18.6%
0.01%
-38.1%
Q2 2017$40,966,000
+8.4%
2,367,940
-30.9%
0.02%0.0%
Q1 2017$37,797,000
+24.8%
3,426,782
+64.3%
0.02%
+23.5%
Q4 2016$30,285,000
-55.3%
2,085,684
-24.4%
0.02%
-58.5%
Q3 2016$67,718,000
+236.1%
2,758,339
+175.7%
0.04%
+215.4%
Q2 2016$20,147,000
-79.9%
1,000,314
-73.7%
0.01%
-80.9%
Q1 2016$99,994,000
-89.3%
3,802,060
-58.5%
0.07%
-88.8%
Q4 2015$931,419,000
+1206.1%
9,162,991
+2191.9%
0.60%
+1086.3%
Q3 2015$71,314,000
-6.9%
399,791
+15.9%
0.05%0.0%
Q2 2015$76,617,000
+14.6%
344,888
+2.4%
0.05%
+10.9%
Q1 2015$66,881,000
-58.7%
336,724
-70.2%
0.05%
-59.3%
Q4 2014$161,812,0001,130,6750.11%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2016
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders